CR 1
Alternative Names: CR-1Latest Information Update: 21 Dec 2022
At a glance
- Originator CUROME BIOSCIENCES
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Inflammation
Most Recent Events
- 06 Dec 2022 Early research in Inflammation in South Korea (unspecified route) (CUROME BIOSCIENCES pipeline, December 2022)